Related Experiment Video
Updated: Feb 12, 2026

Surgical Models of Gastroesophageal Reflux with Mice
Published on: August 25, 2015
Assessment of Esophagogastric Junction Integrity by High-Resolution Manometry Identifies Upright and Recumbent
Edoardo Vespa1,2, Alberto Barchi1,2, Gabriele Altieri1,2
1Division of Gastroenterology and Gastrointestinal Endoscopy, IRCCS Ospedale San Raffaele, Milan, Italy.
Background And Aims:
Esophagogastric junction (EGJ) integrity influences gastroesophageal reflux disease (GERD) pathophysiology, but its association with positional reflux patterns remains unclear. This study evaluated whether upright and recumbent acid exposure differs based on EGJ status on high-resolution manometry (HRM).
Methods:
Retrospective study of patients undergoing HRM and 24-h pH-impedance monitoring off-therapy. EGJ was defined disrupted if any of the following HRM features were present: type II/III morphology, basal pressure < 10.4 mmHg, or EGJ-CI < 9.6 mmHg·cm; intact otherwise. Acid exposure time (AET) and additional reflux metrics were calculated in both positions. Conclusive GERD was defined per Lyon 2.0 (AET > 6%).
Results:
Among 283 patients, 102 (36%) had a disrupted EGJ. These patients showed higher total AET (4.7% vs. 1.9% in the intact EGJ, p < 0.001), primarily driven by recumbent exposure (1.9% vs. 0.2%, p < 0.001). In patients with conclusive GERD (n = 91), total and upright AET were similar across EGJ subgroups, while recumbent AET was significantly higher in the disrupted EGJ group (11.5% vs. 3.1%, p < 0.001). Pathologic recumbent AET (> 6%) and severe esophagitis (LA C-D) were observed only in patients with disrupted EGJ (72% vs. 0%, p < 0.001; 14% vs. 0%, p = 0.015, respectively).
Conclusion:
EGJ integrity stratifies GERD phenotypes by positional pattern: upright-predominant in patients with intact EGJ and recumbent-predominant in those with disrupted EGJ, the latter also associated with severe esophagitis. This suggests distinct pathophysiologic GERD mechanisms depending on EGJ integrity and may guide personalized management.
Related Concept Videos
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Constipation-Predominant IBS
P-N junction
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
The Neuromuscular Junction
Anchoring Junctions

